Nanox (NASDAQ: NNOX) has entered into a distribution agreement with SOLME RC, S.A., a Costa Rica-based medical equipment distributor, to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. The agreement positions Nanox to penetrate Costa Rica's public healthcare system, as SOLME is a registered supplier to the Caja Costarricense de Seguro Social (CCSS), the country's principal purchaser and provider of hospital services.
The significance of this deal lies in its potential to accelerate the adoption of advanced imaging technology in a market where access to such equipment may be limited. By partnering with SOLME, Nanox gains immediate credibility and access to the CCSS, which could lead to widespread deployment of the Nanox.ARC across Costa Rica's public hospitals. This aligns with Nanox's broader vision of driving the world's transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform.
Commercialization will follow applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration. This phased approach allows for clinical validation and adaptation to local needs, potentially smoothing the path to full adoption. Costa Rica represents Nanox's third Latin American market this year, following Argentina and Peru, signaling a strategic push into the region. Latin America often faces challenges in healthcare access, and Nanox's affordable imaging solutions could address unmet needs, improving early detection and clinical efficiency.
The Nanox ecosystem includes the Nanox.ARC, a cost-effective 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability; Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.
By integrating imaging technology, AI, cloud infrastructure, clinical expertise, a marketplace, and health information technology, Nanox seeks to lower barriers to adoption, improve utilization, and advance preventive care worldwide. This agreement is a step toward realizing that vision in Costa Rica, where the CCSS serves as the primary provider. For investors, the move demonstrates Nanox's ability to execute its international expansion strategy, potentially driving revenue growth and reinforcing its position in the global medical imaging market. The full press release can be viewed at https://ibn.fm/C77lJ, and the latest news and updates relating to NNOX are available in the company's newsroom at https://ibn.fm/NNOX. As with any forward-looking statements, risks and uncertainties apply, and readers should refer to the company's SEC filings for more information.
